LTR Pharma Limited (AU:LTP) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
LTR Pharma Limited has issued a cleansing notice for the release of over 27 million shares, ensuring compliance with secondary sale requirements. Additionally, the company announced a significant access agreement with Men’s Health Downunder for the distribution of their product SPONTAN. These developments highlight LTR Pharma’s strategic moves to enhance market presence and shareholder value.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue